Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Cognetivity becomes the ninth industry partner to join DPUK

As experts in platform technology for cognitive assessment, Cognetivity offers DPUK cohorts use of its online testing platform – ‘Integrated Cognitive Assessment’ (ICA). High resolution monitoring offered by Cognetivity’s tests play an important role in shining a light on the elusive early warning signs of dementia. The subtle changes that take place in memory and thinking are still very difficult to detect in its earliest phases.

Cohorts consist of individuals – medical volunteers – involved in long-term studies of health. Affording even the smallest cohorts access to this type of technology can make a big difference to the quality of research data they can collect. The power of their existing data combined with the very latest technology is what characterises DPUK’s mission to accelerate dementia research.

Cognitive assessment: what’s the value of a quick test?

The ICA is a 5-minute computerised assessment tool based on a rapid visual categorisation task, designed to give a sensitive, repeatable measure of overall cognitive function. It is software based, can be self-administered and results are unaffected by participants’ language, culture and education level. This test is designed for use in clinical trials, and cohorts.

Simple assessments like this also reduce the time burden on participants who take part in research. That’s great news for the participants and research teams alike. Together DPUK and Cognetivity can offer a convenient and effective means of collecting high resolution cognitive data on the same individuals. That provides the level of detail that many dementia researchers need for their important work.

AI in dementia research

Artificial intelligence (AI) and machine learning offer much potential in dementia research. Cognetivity, working together with the DPUK consortium scientists, can generate analyses and algorithms that use the breadth of data generated from studies on DPUK cohorts to improve the measurement and diagnosis of the earliest disease stages. The platform’s use of AI allows researchers to examine the relationship between cognition and the changes in measures such as biomarkers, imaging data and genetic factors.

More resources for DPUK cohorts

The ICA, like Cambridge Cognition’s CANTAB software, is one of cognitive testing options that DPUK offers its cohorts. This tool gives precise, fine-tuned measurements of subjects’ ability to process visual information, allowing measurement of cognitive performance by testing different areas of the brain and allowing detection in the pre-symptom phase of dementia.

The value of the partnership for dementia research

Specialist expertise, such as that offered by Cognetivity in cognitive testing, is one of the key benefits of DPUK’s partnership model for brain disease research. The brain is our most complex organ. Cognitive tests are one window into what drives a healthy brain, and what makes it deteriorate – but its real use for treatment development lies in its combination with other types of data. Together, DPUK partners bring expertise in areas such as big data analytics, PET-MR brain scanning and neurology. Bringing experts from all these areas is how we can rise to the challenge posed by dementia. Find out more about our partners’ contributions.